
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 192 pages)
“Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases”, BMC Med Res Methodol, vol. 19, p. 115, 2019.
, “Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records”, Semin Arthritis Rheum, 2019.
, “Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients”, PLoS Med, vol. 16, p. e1002805, 2019.
, “The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients”, Acta Orthop, pp. 1-9, 2019.
, “Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86000 Individuals”, JAMA Cardiol, 2019.
, “Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations”, BMJ Open, vol. 9, p. e031351, 2019.
, “Treatment of first-time traumatic anterior shoulder dislocation: the UK TASH-D cohort study”, Health Technol Assess, vol. 23, pp. 1-104, 2019.
, “ACL and meniscal injuries increase the risk of primary total knee replacement for osteoarthritis: a matched case-control study using the Clinical Practice Research Datalink (CPRD)”, Br J Sports Med, 2018.
, “Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis”, Semin Arthritis Rheum, vol. 47, pp. 605-610, 2018.
, “Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database”, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
, “Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study”, Ann N Y Acad Sci, vol. 1415, pp. 34-46, 2018.
, “Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK”, Osteoporos Int, vol. 29, pp. 467-478, 2018.
, “Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals”, Lancet, vol. 391, pp. 572-580, 2018.
, “Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, 2018.
, “Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study”, J Bone Miner Res, vol. 32, pp. 203-211, 2017.
, “The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study”, Lancet, vol. 389, pp. 1424-1430, 2017.
, “Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study”, Osteoporos Int, vol. 28, pp. 169-178, 2017.
, “Programme Grants for Applied Research”, in Lower limb arthroplasty: can we produce a tool to predict outcome and failure, and is it cost-effective? An epidemiological study, Southampton (UK): NIHR Journals Library Copyright (c) Queen's Printer and Controller of HMSO 2017. This work was produced by Arden et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the pu, 2017.
, “Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients”, Alzheimers Dement (N Y), vol. 3, pp. 612-621, 2017.
, “Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis”, J Bone Miner Res, vol. 31, pp. 2008-2015, 2016.
, “Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England”, Health Services and Delivery Research, vol. No. 4.28, 2016.
, “Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom”, Rheumatology (Oxford), vol. 54, pp. 2244-8, 2015.
, “Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink”, Osteoarthritis Cartilage, vol. 23, pp. 594-600, 2015.
, “Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study”, Ann Rheum Dis, vol. 74, pp. 557-63, 2015.
, “The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery”, Osteoarthritis Cartilage, vol. 22, pp. 918-27, 2014.
, ,
“The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database”, Osteoarthritis Cartilage, vol. 20, pp. 519-24, 2012.
, “Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study”, Bmj, vol. 343, p. d7222, 2011.
, “Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study”, Ann Rheum Dis, vol. 70, pp. 134-8, 2011.
, “Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use”, Arthritis Rheum, vol. 63, pp. 992-1001, 2011.
,